AdvisorShares Insider Advantage ETF

Marvell Technology Scheduled to Release Q1 FY2027 Earnings on May 27

Fortinet Hosts Hanoi Meeting: Focusing on AI-Driven Cybersecurity Threats and Defense

ByteDance Raises 2026 AI Capex to Over 200 Billion RMB, Qualcomm Launches Edge AI Platform to Boost Trillion-Yuan Market

Marvell Tech to Release FY2027 Q1 Earnings on May 27 After-Market EST, Forecast Revenue USD 2.399 B, EPS USD 0.3243

Qualcomm CFO: Company to Launch Multiple New Products from September to December Quarter

Qualcomm CFO: Leveraging Business Scale to Secure Supply Chain Allocation

Amazon and AMD Increase Holdings in Marvell, Highlighting Potential to Replace Nvidia in AI

DZ Bank Downgrades Fortinet Rating to 'Hold', Sets Target Price at $125

Larson Financial Group Increases Caterpillar Stake by 73.6% to $7.4M Amid Insider Selling

TD Private Client Wealth LLC Reduces Stake in Applied Materials by 24%

RiverFront Increases Qualcomm Stake by 48.1% to 8,038 Shares, Qualcomm Announces $20B Buyback Plan

Hartford Funds Acquires 2,962 Caterpillar Shares in Q4 Worth ~$1.7M

DaVita Sets 2030 ESG Goals: Focusing on Patient Transplants, Workforce Development, and 100% Renewable Energy

Marvell Technology CFO Willem A. Meintjes Sells 4,000 Shares

Morgan Stanley downgrades Applied Materials to Hold, maintains $520 median target price

Qualcomm Announces 2026 QITC Edge AI Contest Finalists, Focusing on 10 Taiwanese Startups

RiverFront Investment Group Increases CAT Stake by 21.1% in Q4, Analysts Raise Rating to $1,045

Cambridge Investment Increases AMAT Stake by 2.8%, Company Beats Earnings and Raises Dividend

Zacks Raises Caterpillar's 2026 Q4 EPS Estimate to $6.27

Marvell Technology Options Trading Active: Call Volume Hits 68%, Specific Put Options See Surge

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

SURE

As global markets rally, small-cap stocks are thriving, with the Russell 2000 index showing significant gains. Investors are encouraged to explore undervalued small-cap companies with insider buying for potential growth. Notable picks include Region Group, Chemtrade Logistics Income Fund, and Chorus Aviation, each demonstrating strong operational performance and strategic capital management despite market challenges. These companies are highlighted for their insider confidence and share repurchase programs, indicating potential value for investors. A full list of 159 undervalued small caps is available for further insights.

Simplywall

Regions Financial

Direxion Small Cap Bull 3X

Vanguard Russell 2000 Value

Vanguard Russell 2000 Growth

Pro Rsl 2000 Dvd Grw

VG S-Cp Value

Global X Russell 2000 ETF

Vanguard Russell 2000

Avantis Int Small Cap Value

ProShares Ultra Russell2000 ETF

ProShares Russell 2000 High Income ETF

ISHRS Russ 2000 Growth

iShares Russell 2000

SHOUCHENG B2607

Centurion

Young & Co.'s Brewery, P.L.C. Class A

Young & Co.'s Brewery, P.L.C.

CapLand China T

April 2026's Global Undervalued Small Caps With Insider Buying

ACHR

ARKX

JETS

ARCX

Archer Aviation Inc. (ACHR) reported that two senior executives, CTO Thomas Muniz and Chief Legal and Strategy Officer Eric Lentell, received 78,659 shares each of Class A common stock as part of a performance-based pay plan. The shares were awarded at $0, indicating they were granted as compensation. This insider activity has turned negative despite the strong stock awards, as disclosed in recent filings with the U.S. Securities and Exchange Commission.

Tip Ranks

Archer Aviation

SPDR S&P Aerospace & Def

Invesco Aero & Defense ETF

ISHRS Aero & Def

ARK Space Exploration & Innovation ETF

Us Global Jets

Tradr 2X Long ACHR Daily ETF

ARCHER AVIATION INC C/WTS 16/09/2026 (TO PUR COM)

Archer Aviation (ACHR) Insider Activity Turns Negative Despite Strong Stock Awards

FIGR

June Ou, a 10% owner and director of Figure Technology Solutions, sold 67,840 shares for $2,387,554 on April 15, 2026. Following this transaction, Ou controls a total of 6,146,654 Class A common shares, with 6,128,993 held directly and 17,661 controlled indirectly, as reported in a recent SEC filing.

Fidelity

Figure Tech Solutions - CL

Figure Technology Solutions Insider Sold Shares Worth $2,387,554, According to a Recent SEC Filing

Mindflair investors to get portfolio update via Sure Valley Ventures webinar

Mindflair investors to get portfolio update via Sure Valley Ventures webinar

Archer Aviation (ACHR) has seen its stock fall 17% year-to-date, following new filings with the U.S. Securities and Exchange Commission that reveal insider sales and a minor stock issuance related to vendor payments. The filings also allow for trading of shares from a previous deal. These actions do not generate new cash for the company, which is preparing for its air taxi launch. On Friday, ACHR shares dropped 3.10%, closing at $6.26.

iShares US Transportation ETF

SPDR S&P Transp

Archer Aviation (ACHR) Stock Falls 17% YTD as Filings Reveal Insider Sales and New Share Issuance

ARKK

AADR

The maker of electric vertical takeoff and landing, or eVTOL, aircraft reports a quarterly Ebitda loss of $137.9 million from sales of less than $1 million.

Ark Innovation ETF

AdvisorShares Dorsey Wright

WisdomTree Battery Value Chain and Innovation Fund - ETF

AdvisorShares Equity Focused

ARK Autonomous Tech & Robotics ETF

Tema Electrification ETF

Archer Aviation stock falls after earnings. Why the eVTOL maker is tumbling.

DAPP

BKKT

Six analysts have recently evaluated Figure Technology (NASDAQ:FIGR), showing a mix of bullish and bearish sentiments. The average 12-month price target is now $65.5, up from $59.00, with a high estimate of $75.00 and a low of $55.00. Key analysts have adjusted their ratings, with some raising targets in response to market conditions. Financially, Figure Technology shows strong revenue growth of 86.84% and a net margin of 32.45%, although its return on equity is below industry averages. The company maintains a conservative debt-to-equity ratio of 0.69, indicating lower reliance on debt financing.

- Over the past three months, 6 analysts have shown varied ratings for Figure Technology, revealing a shift from bullish trends with 3 current ratings to a decrease in recent bullish sentiment.  
- Analyst expectations indicate an average 12-month price target of $65.5, increasing from $59.00, with key analysts raising their price targets in response to market conditions.  
- Financial metrics show that Figure Technology experienced significant revenue growth at approximately 86.84% and maintains a strong net margin of 32.45%, despite facing challenges with ROI.

benzinga_article

VanEck Digital Transformation ETF

Bakkt

Financial Select Sector SPDR Fund

Fidelity Nasdaq Composite Index ETF

VG S-Cp Grw

Amplify Transform Data Sharing ETF

GameStop

Ps Senior Loan

Grayscale Litecoin Trust (LTC)

Doubleline Mortgage ETF

SPDR Portfolio Mortgage Backed Bond ETF

Grayscale Solana Staking ETF

Fidelity MSCI Financials Index

Vanguard Mortgage Backed Sec

ISHRS S&P Glb It

SPDR S&P Semicon

First Trust Innovation Leaders ETF

VG Financial

Siren ETF Trust Siren Nasdaq NexGen Economy ETF

Bitwise Solana Staking ETF

Roundhill Bitcoin Covered Call Strategy ETF

Global X Fintech

VanEck Onchain Economy ETF

Coinbase

ISHRS Us Brokers & Sec Exchg

ARK Fintech Innovation ETF

Bitwise Crypto Innovators ETF

Robinhood

Invesco Semiconductors ETF

First Trust Indxx Innov

VanEck Semiconductor ETF

BNY Mellon US Mid Cap Core Equity ETF

iShares Barclays MBS Fixed Rate Bd

iShares Semiconductor ETF

Galaxy Digital

Beyond The Numbers: 6 Analysts Discuss Figure Technology Stock

SureNano Science Ltd. has acquired GlucaPharm Inc., enhancing its position in the GLP-1 drug market with the development of GEP44, a novel peptide aimed at obesity and metabolic diseases. The acquisition involves issuing 8,100,999 common shares and warrants to GlucaPharm shareholders. Dr. Nihar R. Pandey has been appointed as Chief Scientific Officer. GEP44 aims to provide improved tolerability and delivery methods compared to existing GLP-1 therapies. The company anticipates key development milestones in the coming months, positioning itself in a rapidly growing pharmaceutical market.

StockTitan

SureNano Science Ltd. Acquires GlucaPharm Inc., Advancing Second-Generation FDA Pathway GLP-1 Drug Development | SURNF Stock News

AdvisorShares Insider Advantage ETF(SURE.US)

April 2026's Global Undervalued Small Caps With Insider Buying

Archer Aviation (ACHR) Insider Activity Turns Negative Despite Strong Stock Awards

Figure Technology Solutions Insider Sold Shares Worth $2,387,554, According to a Recent SEC Filing

Mindflair investors to get portfolio update via Sure Valley Ventures webinar

Archer Aviation (ACHR) Stock Falls 17% YTD as Filings Reveal Insider Sales and New Share Issuance